Global Biochemistry Analyzers Market Serves Critical Function of Accurate Diagnosis
The global biochemistry analyzers market has been thriving with their increasing use in hospitals, clinics, and laboratories due to their ability to provide quick and accurate results. Biochemistry analyzers assess blood and urine samples for toxins that could indicate an illness. This has made the process of diagnosis and treatment significantly faster than before. With biochemistry analyzers, this period has been reduced to less than an hour, benefitting both doctors and patients alike. They are primarily used for the identification of blood, urine, or saliva samples.
The demand for analyzers is expected to grow rapidly due to an increase in the number of tests being performed on patients as conditions such as diabetes, high blood pressure, renal diseases, and others continue to have a high prevalence. Introduction of newer in development of biochemistry analyzers is expected to improve healthcare outcomes for those suffering from chronic diseases. As these high-end technologies become cheaper and easier to use, more number of individuals will likely seek treatment at hospitals rather than at their local clinic or doctor's office.
With chronic conditions such as diabetes, obesity, hypertension, kidney disease, and high cholesterol amongst others—and technological advances leading to cheaper prices while increasing usability—the demand for biochemistry analyzers is growing.
Right Combination of Price and Features are Key Determinants for Product Demand
Today, the global biochemistry analyzers market is flooded with different types of machines with a wide range of features and prices. However, the demand for such products relies mainly on various features available in a machine since not all biochemistry analyzers are made equal, there are some biochemistry analyzers that measure specific parameters only while others measure a comprehensive set of tests. Some may provide results in seconds while others take a much longer time to give results.
For instance, some biochemistry analyzers perform up to 120 different tests using 20-30 different reagents. This kind of machine can also give a patient's medical history which aids in finding an accurate diagnosis for his or her condition. This saves the patients from going through needless testing and being charged high fees for it.
There are other features that biochemistry analyzers have started to provide over the past few years such as sample tracking (which records details like when a patient was given his or her test results), data storage (so reports can be easily printed at any time required), and wireless printing (also known as Wi-Fi). The main purpose of these additional features is to make the entire testing process much more efficient.
The biochemistry analyzers are available in various prices depending on the product specifications, quantity required and where they are bought from. For example, a product of good quality may cost nearly $2,000 but products of relatively low quality may be bought for as less as $1,000 or more. The price of biochemistry analyzers also varies between different models and brands. However, lower-priced models usually have fewer features than those that are expensive.
Biochemistry Analyzers to Boost Clinical Diagnostic Revolution
Biochemistry analyzers are important instruments used in clinical laboratories to diagnose diseases. They help determine the chemical components present in the blood, urine, or other body fluids. Biochemistry analyzers provide information about levels of electrolytes, enzymes, metabolites, and nutrients that are associated with various conditions. Healthcare professionals also use them to monitor patients who are undergoing dialysis for chronic renal failure. Blood samples taken from the patient are analyzed by a machine that provides accurate measurements of electrolytes such as sodium, potassium chloride, and bicarbonate ions. The electronic readouts generated by this equipment can be used to adjust dietary intake or prescribe medications if levels of any ion are found to be abnormal.
In clinical laboratories, biochemistry analyzers are routinely used to detect medical conditions such as urea cycle disorder and congenital adrenal hyperplasia. A diagnostic test for this condition is performed using tandem mass spectrometry which is another instrument based on the principles of electrophoresis. Tandem mass spectrometers produce isotopic patterns that allow scientists to measure molecular masses and establish chemical formulas for organic compounds. This technique is used to analyze two proteins associated with the urea cycle disorder. A patient's urine sample is first ionized by an electrospray ionization process, and the electrically charged particles are sorted out based on their mass-to-charge ratio. The separated ions can then be detected by a tandem mass spectrometer which detects the fragments produced because of collision-induced decomposition of precursor ions.
Biochemistry analyzers also play a critical role in various medical research projects such as studies related to hepatitis C virus infection. This device uses electric fields to sort DNA fragments by lengths and determine the number of hepatitis C virus particles in each blood sample. Moreover, they are used to detect other conditions such as phenylketonuria (PKU) which is a genetic disorder affecting amino acid metabolism. Other conditions diagnosed with the help of biochemistry analyzers include maple syrup urine disease, homocystinuria, and hyperlysinem among others. All these diseases result from the lack of specific enzymes needed for processing amino acids. In maple syrup urine disease, patients have a distinctive sweet odor in their urine because they cannot break down branched chain ketoacids. The condition is diagnosed by measuring these acids using tandem mass spectrometry.
Major Players Active in Global Biochemistry Analyzers Market
Some of the key players operating in the global biochemistry analyzers market are Roche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., Abbott Diagnostics Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Hologic, Inc., Randox Laboratories Ltd., Awareness Technology, Inc., Transasia Biomedicals Ltd, and Nova Biomedical Corp.
Please Note: The above mentioned segmentation/companies/countries are likely to differ in the actual report as they are based on preliminary research.
Under uncertainty, traditional approaches to strategic planning can be downright dangerous. True ambiguity is no basis to forecast the future – degree of risk, the magnitude of circumstances, conditions and consequences are not known or unpredictable. To avoid dangerous binary views of uncertainty; strategic posture, moves and actions through market research is the best bet.Read more